[ad_1]
The Guardant360 test detects DNA segments in the patient's blood from the cancerous tumor or its metastasis
Image of representation
Israeli researchers have discovered a method to tailor specific treatment to lung cancer patients through simple blood tests, reported Monday the Hebrew website "Ynet".
The study, conducted by the Oncology Department of Soroka Hospital in southern Israel, examined the contribution of the use of noninvasive liquid biopsy. "Guardant360" to ensure accurate treatment of patients with metastases.
The Guardant360 test detects DNA segments in the patient's blood from the cancerous tumor or its metastases.
After examining 116 patients with advanced non-small cell lung carcinoma cancer, the study concluded that 65% of patients had a genetic modification that could be treated with US-approved drugs. Food and Drug Administration.
Catch up on all the news Crime, national news, international and Hatke right here. Download also the new midi Android and iOS apps to get the latest updates
This story was extracted from an outsourced third party, the agencies. With the exception of the title change, the article has been provided "AS IS", "AS AVAILABLE, WITHOUT ANY VERIFICATION OR RELEASE FROM OUR PARTY." Mid-day accepts no liability for its reliability, reliability, reliability and Mid-day management / mid-day.com reserves the exclusive right to modify, delete or delete (without notice) the content, at its sole discretion, for any reason whatsoever.
Source link
